Acute Porphyria Drug Database

Popular Drugs

This is a list of the 300 most prescribed drugs in the United States in 2022, along with their risk classifications and brand names from selected countries.
Risk
Click drug name for details
C10AA05 · ATORVASTATIN LIPID MODIFYING AGENTS
A10BA02 · METFORMIN DRUGS USED IN DIABETES
C09AA03 · LISINOPRIL AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM
H03AA01 · LEVOTHYROXINE THYROID THERAPY
C08CA01 · AMLODIPINE CALCIUM CHANNEL BLOCKERS
C07AB02 · METOPROLOL BETA BLOCKING AGENTS
R03AC02 · ALBUTEROL DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES
C09CA01 · LOSARTAN AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM
A02BC01 · OMEPRAZOLE DRUGS FOR ACID RELATED DISORDERS
N02BF01 · GABAPENTIN ANALGESICS
N06AB06 · SERTRALINE PSYCHOANALEPTICS
C03AA03 · HYDROCHLOROTHIAZIDE DIURETICS
C10AA07 · ROSUVASTATIN LIPID MODIFYING AGENTS
N06BA02 · DEXTROAMPHETAMINE; DEXTROAMPHETAMINE SACCHARATE; AMPHETAMINE; AMPHETAMINE ASPARTATE PSYCHOANALEPTICS
N06AB10 · ESCITALOPRAM PSYCHOANALEPTICS
A02BC02 · PANTOPRAZOLE DRUGS FOR ACID RELATED DISORDERS
R03DC03 · MONTELUKAST DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES
N06AX05 · TRAZODONE PSYCHOANALEPTICS
C10AA01 · SIMVASTATIN LIPID MODIFYING AGENTS
G04CA02 · TAMSULOSIN UROLOGICALS
N06AX12 · BUPROPION PSYCHOANALEPTICS
N06AB03 · FLUOXETINE PSYCHOANALEPTICS
C03CA01 · FUROSEMIDE DIURETICS
R03BA05 · FLUTICASONE DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES
J01CA04 · AMOXICILLIN ANTIBACTERIALS FOR SYSTEMIC USE
B01AF02 · APIXABAN ANTITHROMBOTIC AGENTS
A10AE04 · INSULIN GLARGINE DRUGS USED IN DIABETES
M01AC06 · MELOXICAM ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS
H02AB07 · PREDNISONE CORTICOSTEROIDS FOR SYSTEMIC USE
N06AX21 · DULOXETINE PSYCHOANALEPTICS
N06BA04 · METHYLPHENIDATE PSYCHOANALEPTICS
M01AE01 · IBUPROFEN ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS
C07AG02 · CARVEDILOL BETA BLOCKING AGENTS
B05XA01 · POTASSIUM CHLORIDE BLOOD SUBSTITUTES AND PERFUSION SOLUTIONS
B01AC06 · ASPIRIN ANTITHROMBOTIC AGENTS
C10AA03 · PRAVASTATIN LIPID MODIFYING AGENTS
M04AA01 · ALLOPURINOL ANTIGOUT PREPARATIONS
N06AB04 · CITALOPRAM PSYCHOANALEPTICS
N05BA12 · ALPRAZOLAM PSYCHOLEPTICS
A10BB07 · GLIPIZIDE DRUGS USED IN DIABETES
N06AX16 · VENLAFAXINE PSYCHOANALEPTICS
N05BB01 · HYDROXYZINE PSYCHOLEPTICS
B01AC04 · CLOPIDOGREL ANTITHROMBOTIC AGENTS
A10BJ06 · SEMAGLUTIDE DRUGS USED IN DIABETES
A02BA03 · FAMOTIDINE DRUGS FOR ACID RELATED DISORDERS
G03CA03 · ESTRADIOL SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM
S01BC03 · DICLOFENAC OPHTHALMOLOGICALS
C03DA01 · SPIRONOLACTONE DIURETICS
C09BA03 · HYDROCHLOROTHIAZIDE; LISINOPRIL AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM
N05BE01 · BUSPIRONE PSYCHOLEPTICS
N02AX02 · TRAMADOL ANALGESICS
A10BK03 · EMPAGLIFLOZIN DRUGS USED IN DIABETES
N03AE01 · CLONAZEPAM ANTIEPILEPTICS
N03AX09 · LAMOTRIGINE ANTIEPILEPTICS
R03AK06 · FLUTICASONE; SALMETEROL DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES
N02AA05 · OXYCODONE ANALGESICS
A04AA01 · ONDANSETRON ANTIEMETICS AND ANTINAUSEANTS
A11CC05 · CHOLECALCIFEROL VITAMINS
C07AB03 · ATENOLOL BETA BLOCKING AGENTS
A10BB12 · GLIMEPIRIDE DRUGS USED IN DIABETES
B03BB01 · FOLIC ACID ANTIANEMIC PREPARATIONS
N05CF02 · ZOLPIDEM PSYCHOLEPTICS
S01EE01 · LATANOPROST OPHTHALMOLOGICALS
J01AA02 · DOXYCYCLINE ANTIBACTERIALS FOR SYSTEMIC USE
N06BA12 · LISDEXAMFETAMINE PSYCHOANALEPTICS
A10AB04 · INSULIN LISPRO DRUGS USED IN DIABETES
C02AC01 · CLONIDINE ANTIHYPERTENSIVES
R06AX13 · LORATADINE ANTIHISTAMINES FOR SYSTEMIC USE
G04CB01 · FINASTERIDE UROLOGICALS
A10BJ05 · DULAGLUTIDE DRUGS USED IN DIABETES
C09DA01 · HYDROCHLOROTHIAZIDE; LOSARTAN AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM
A10AB05 · INSULIN ASPART DRUGS USED IN DIABETES
C07AA05 · PROPRANOLOL BETA BLOCKING AGENTS
J01FA10 · AZITHROMYCIN ANTIBACTERIALS FOR SYSTEMIC USE
C10AX09 · EZETIMIBE LIPID MODIFYING AGENTS
G03AA05 · ETHINYL ESTRADIOL; NORETHINDRONE SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM
N05BA06 · LORAZEPAM PSYCHOLEPTICS
N05AH04 · QUETIAPINE PSYCHOLEPTICS
R03AK07 · BUDESONIDE; FORMOTEROL DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES
N03AX11 · TOPIRAMATE ANTIEPILEPTICS
B01AA03 · WARFARIN ANTITHROMBOTIC AGENTS
A10BH01 · SITAGLIPTIN DRUGS USED IN DIABETES
N06AA09 · AMITRIPTYLINE PSYCHOANALEPTICS
C10AB05 · FENOFIBRATE LIPID MODIFYING AGENTS
M01AE02 · NAPROXEN ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS
B01AF01 · RIVAROXABAN ANTITHROMBOTIC AGENTS
N02BF02 · PREGABALIN ANALGESICS
N06AB05 · PAROXETINE PSYCHOANALEPTICS
M01AH01 · CELECOXIB ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS
N02CC01 · SUMATRIPTAN ANALGESICS
J01CR02 · AMOXICILLIN; CLAVULANATE ANTIBACTERIALS FOR SYSTEMIC USE
G03AA11 · ETHINYL ESTRADIOL; NORGESTIMATE SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM
C08DB01 · DILTIAZEM CALCIUM CHANNEL BLOCKERS
J01DB01 · CEPHALEXIN ANTIBACTERIALS FOR SYSTEMIC USE
S01BA05 · TRIAMCINOLONE OPHTHALMOLOGICALS
M05BA04 · ALENDRONATE DRUGS FOR TREATMENT OF BONE DISEASES
M03BX01 · BACLOFEN MUSCLE RELAXANTS
N06AX11 · MIRTAZAPINE PSYCHOANALEPTICS
N05AX12 · ARIPIPRAZOLE PSYCHOLEPTICS
B03AA07 · FERROUS SULFATE ANTIANEMIC PREPARATIONS
G04BD04 · OXYBUTYNIN UROLOGICALS
C10AA02 · LOVASTATIN LIPID MODIFYING AGENTS
P01BA02 · HYDROXYCHLOROQUINE ANTIPROTOZOALS
J05AB11 · VALACYCLOVIR ANTIVIRALS FOR SYSTEMIC USE
N02BE01 · ACETAMINOPHEN ANALGESICS
A10BK01 · DAPAGLIFLOZIN DRUGS USED IN DIABETES
C09CA03 · VALSARTAN AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM
G03BA03 · TESTOSTERONE SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM
C01DA14 · ISOSORBIDE CARDIAC THERAPY
A10BG03 · PIOGLITAZONE DRUGS USED IN DIABETES
C02DB02 · HYDRALAZINE ANTIHYPERTENSIVES
A02BC05 · ESOMEPRAZOLE DRUGS FOR ACID RELATED DISORDERS
N03AX14 · LEVETIRACETAM ANTIEPILEPTICS
S01GX07 · AZELASTINE OPHTHALMOLOGICALS
G03DA04 · PROGESTERONE SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM
M03BA03 · METHOCARBAMOL MUSCLE RELAXANTS
A10AE05 · INSULIN DETEMIR DRUGS USED IN DIABETES
G03AA07 · ETHINYL ESTRADIOL; LEVONORGESTREL SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM
R06AE05 · MECLIZINE ANTIHISTAMINES FOR SYSTEMIC USE
B03BA01 · CYANOCOBALAMIN ANTIANEMIC PREPARATIONS
L04AX03 · METHOTREXATE IMMUNOSUPPRESSANTS
P01AB01 · METRONIDAZOLE ANTIPROTOZOALS
J05AB01 · ACYCLOVIR ANTIVIRALS FOR SYSTEMIC USE
G03AC01 · NORETHINDRONE SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM
H02AB06 · PREDNISOLONE CORTICOSTEROIDS FOR SYSTEMIC USE
A10AE06 · INSULIN DEGLUDEC DRUGS USED IN DIABETES
A10BJ02 · LIRAGLUTIDE DRUGS USED IN DIABETES
N02AA01 · MORPHINE ANALGESICS
C09AA02 · ENALAPRIL AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM
G03AA12 · DROSPIRENONE; ETHINYL ESTRADIOL SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM
J01EE01 · SULFAMETHOXAZOLE; TRIMETHOPRIM ANTIBACTERIALS FOR SYSTEMIC USE
N06DA02 · DONEPEZIL PSYCHOANALEPTICS
J01FF01 · CLINDAMYCIN ANTIBACTERIALS FOR SYSTEMIC USE
N06DX01 · MEMANTINE PSYCHOANALEPTICS
C08CA05 · NIFEDIPINE CALCIUM CHANNEL BLOCKERS
H02AB04 · METHYLPREDNISOLONE CORTICOSTEROIDS FOR SYSTEMIC USE
R03BB04 · TIOTROPIUM DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES
S01ED01 · TIMOLOL OPHTHALMOLOGICALS
D07AD01 · CLOBETASOL CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS
G04BE03 · SILDENAFIL UROLOGICALS
J01XE01 · NITROFURANTOIN ANTIBACTERIALS FOR SYSTEMIC USE
J02AC01 · FLUCONAZOLE ANTIMYCOTICS FOR SYSTEMIC USE
G03AA09 · DESOGESTREL; ETHINYL ESTRADIOL SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM
N04BC04 · ROPINIROLE ANTI-PARKINSON DRUGS
N03AF02 · OXCARBAZEPINE ANTIEPILEPTICS
N05BA01 · DIAZEPAM PSYCHOLEPTICS
N05AH03 · OLANZAPINE PSYCHOLEPTICS
G04BE08 · TADALAFIL UROLOGICALS
N03AG01 · VALPROATE ANTIEPILEPTICS
J02AB02 · KETOCONAZOLE ANTIMYCOTICS FOR SYSTEMIC USE
R03BA02 · BUDESONIDE DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES
L02BG03 · ANASTROZOLE ENDOCRINE THERAPY
C02CA04 · DOXAZOSIN ANTIHYPERTENSIVES
A10BD07 · METFORMIN; SITAGLIPTIN DRUGS USED IN DIABETES
N05AX08 · RISPERIDONE PSYCHOLEPTICS
C03CA04 · TORSEMIDE DIURETICS
L04AD01 · CYCLOSPORINE IMMUNOSUPPRESSANTS
C09AA05 · RAMIPRIL AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM
C08DA01 · VERAPAMIL CALCIUM CHANNEL BLOCKERS
N02CC04 · RIZATRIPTAN ANALGESICS
N06AA10 · NORTRIPTYLINE PSYCHOANALEPTICS
A10AB01 · INSULIN HUMAN; INSULIN ISOPHANE HUMAN DRUGS USED IN DIABETES
N04BC05 · PRAMIPEXOLE ANTI-PARKINSON DRUGS
G02BB01 · ETHINYL ESTRADIOL; ETONOGESTREL OTHER GYNECOLOGICALS
C01DA02 · NITROGLYCERIN CARDIAC THERAPY
M04AC01 · COLCHICINE ANTIGOUT PREPARATIONS
R06AD02 · PROMETHAZINE ANTIHISTAMINES FOR SYSTEMIC USE
S01EA05 · BRIMONIDINE OPHTHALMOLOGICALS
C09CA04 · IRBESARTAN AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM
S01EC03 · DORZOLAMIDE OPHTHALMOLOGICALS
B01AC24 · TICAGRELOR ANTITHROMBOTIC AGENTS
H03AA02 · LIOTHYRONINE THYROID THERAPY
J05AH02 · OSELTAMIVIR ANTIVIRALS FOR SYSTEMIC USE
A12CC30 · MAGNESIUM SALTS MINERAL SUPPLEMENTS
A06AD15 · POLYETHYLENE GLYCOL 3350 DRUGS FOR CONSTIPATION
G04BD08 · SOLIFENACIN UROLOGICALS
N05AN01 · LITHIUM PSYCHOLEPTICS
N06BA09 · ATOMOXETINE PSYCHOANALEPTICS
A02BX02 · SUCRALFATE DRUGS FOR ACID RELATED DISORDERS
C07AG01 · LABETALOL BETA BLOCKING AGENTS
A12CA01 · SODIUM SALTS MINERAL SUPPLEMENTS
N05CH01 · MELATONIN PSYCHOLEPTICS
R03BB01 · IPRATROPIUM DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES
G04BD12 · MIRABEGRON UROLOGICALS
A02BC03 · LANSOPRAZOLE DRUGS FOR ACID RELATED DISORDERS
S01ED51 · DORZOLAMIDE; TIMOLOL OPHTHALMOLOGICALS
A11GA01 · ASCORBIC ACID VITAMINS
L04AA06 · MYCOPHENOLATE MOFETIL IMMUNOSUPPRESSANTS
C09CA07 · TELMISARTAN AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM
C10AB04 · GEMFIBROZIL LIPID MODIFYING AGENTS
N02AA03 · HYDROMORPHONE ANALGESICS
H02AB02 · DEXAMETHASONE CORTICOSTEROIDS FOR SYSTEMIC USE
C01BD01 · AMIODARONE CARDIAC THERAPY
M01AX01 · NABUMETONE ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS
S01EA01 · EPINEPHRINE OPHTHALMOLOGICALS
L04AB04 · ADALIMUMAB IMMUNOSUPPRESSANTS
D01AC20 · BETAMETHASONE; CLOTRIMAZOLE ANTIFUNGALS FOR DERMATOLOGICAL USE
S01GX08 · KETOTIFEN OPHTHALMOLOGICALS
A11HA03 · VITAMIN E VITAMINS
A03FA01 · METOCLOPRAMIDE DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS
A12AX · CALCIUM PHOSPHATE; CHOLECALCIFEROL MINERAL SUPPLEMENTS
C07AB07 · BISOPROLOL BETA BLOCKING AGENTS
S01GX09 · OLOPATADINE OPHTHALMOLOGICALS
J01MA12 · LEVOFLOXACIN ANTIBACTERIALS FOR SYSTEMIC USE
A09AA02 · PANCRELIPASE AMYLASE; PANCRELIPASE LIPASE; PANCRELIPASE PROTEASE DIGESTIVES, INCL. ENZYMES
D01BA02 · TERBINAFINE ANTIFUNGALS FOR DERMATOLOGICAL USE
M01AB01 · INDOMETHACIN ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS
R06AX26 · FEXOFENADINE ANTIHISTAMINES FOR SYSTEMIC USE
J01CE02 · PENICILLIN V ANTIBACTERIALS FOR SYSTEMIC USE
R06AD52 · DEXTROMETHORPHAN; PROMETHAZINE ANTIHISTAMINES FOR SYSTEMIC USE
A06AG10 · SENNA; DOCUSATE DRUGS FOR CONSTIPATION
R01BA52 · BROMPHENIRAMINE; DEXTROMETHORPHAN; PSEUDOEPHEDRINE NASAL PREPARATIONS
A06AD11 · LACTULOSE DRUGS FOR CONSTIPATION
L01BC02 · FLUOROURACIL ANTINEOPLASTIC AGENTS
J01MA14 · MOXIFLOXACIN ANTIBACTERIALS FOR SYSTEMIC USE
L02AB02 · MEDROXYPROGESTERONE ENDOCRINE THERAPY
N04BA02 · CARBIDOPA; LEVODOPA ANTI-PARKINSON DRUGS
A06AB06 · SENNOSIDES DRUGS FOR CONSTIPATION
S01AA12 · TOBRAMYCIN OPHTHALMOLOGICALS
A06AD65 · POLYETHYLENE GLYCOL 3350 WITH ELECTROLYTES DRUGS FOR CONSTIPATION
J01DC02 · CEFUROXIME ANTIBACTERIALS FOR SYSTEMIC USE
G03AA12 · DROSPIRENONE; ETHINYL ESTRADIOL; LEVOMEFOLATE SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM
S03CA01 · CIPROFLOXACIN; DEXAMETHASONE OPHTHALMOLOGICAL AND OTOLOGICAL PREPARATIONS
A11DA01 · THIAMINE VITAMINS
R01BA52 · LORATADINE; PSEUDOEPHEDRINE NASAL PREPARATIONS
R06AX02 · CYPROHEPTADINE ANTIHISTAMINES FOR SYSTEMIC USE
R05CA03 · GUAIFENESIN COUGH AND COLD PREPARATIONS
A07DA03 · LOPERAMIDE ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS
D10AX03 · AZELATE ANTI-ACNE PREPARATIONS
The prescription data is published by the U.S. Government. Source: ClinCalc.com. Information about the drug properties and published evidence on porphyrinogenicity can be be accessed by clicking on the drug names.

 
© NAPOS 2024
An unhandled error has occurred. Reload 🗙